GLP-1 Dual Agonist (TRZ) 60mg

GLP-1 Dual Agonist (TRZ) is a synthetic dual-incretin peptide that concurrently activates the GLP-1 and GIP receptors. As a pioneering "twincretin" investigational compound, it demonstrates a balanced yet highly potent profile at both incretin receptors, leading to enhanced insulin secretion, glucagon suppression, delayed gastric emptying, and significant metabolic improvements. It has been widely studied in large-scale trials for its superior effects on glycemic control and body weight reduction compared to GLP-1-only agonists.

Benefits:

• Drives substantial, dose-dependent body weight reduction through amplified satiety, reduced caloric intake, and metabolic enhancement
• Provides robust improvement in glucose homeostasis via glucose-dependent insulin release and glucagon modulation
• Supports favorable changes in lipid metabolism and cardiometabolic risk factors in research models

Disclaimer: This product is intended for research purposes only and is not approved for human or veterinary use.